JHC exPRESS: First Published December 22, 2006. doi:10.1369/jhc.6A7129.2006 Journal of Histochemistry and Cytochemistry Copyright © 2006 Groenman et al. A more recent version of this article appeared on April 1, 2007.
Hypoxia Inducible Factors in the First Trimester Human Lung
1 Canadian Institutes of Health Research (CIHR) Group in Lung Development, Hospital for Sick Children Research Institute, Department of Pediatrics and Institute of Medical Sciences (FAG,MR,MP) and Department of Obstetrics and Gynaecology, Mount Sinai Hospital (IC), University of Toronto, Toronto, Canada, and Department of Pediatric Surgery, Erasmus MC-Sophia, Rotterdam, The Netherlands (FAG,DT)
* To whom correspondence should be addressed. E-mail: martin.post{at}sickkids.ca.
subunit. The interaction with VHL requires hydroxylation of HIF-1 proline residues by prolyl hydroxylases (PHDs). Herein, we investigated the expression of the various components regulating HIF-1 stability in first trimester (8-14 wks) human lungs. Spatial expression was assessed by immunohistochemistry and temporal expression by quantitative PCR. Immunoreactivity for PHD1, PHD3, and seven in absentia homologue (SIAH)1 was noted in the pulmonary epithelium. PHD2 was not expressed in the airway epithelium, but in the lung parenchyma. HIF-1 and Vascular endothelial growth factor (VEGF) immunoreactivity was primarily detected in the branching epithelium. HIF-2 and ARNT proteins localized to the developing epithelium as well as mesenchymal, most likely vascular, structures in the parenchyma. VEGF receptor 2 (VEGFR2) was found in the subepithelium as well as in vascular structures of the mesenchyme. All components of the VEC complex (VHL, NEDD8, and Cullin2) were found in the epithelium. Quantitative PCR analysis demonstrated that VEGF, VEGFR1, HIF-1 , HIF-2 , ARNT, PHD1, PHD2, PHD3 and SIAH1 gene expression was constant during early pulmonary organogenesis. Cumulatively, the data suggest that the lung develops in a low oxygen environment which allows for proper vascular development through HIF regulated pathways.
Key Words: pulmonary vascularization, hypoxia inducible factor, development, human
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||